What is Hollison?
Hollison operates at the intersection of biotechnology and industrial manufacturing, providing a comprehensive suite of probiotic solutions and precision sampling systems. The company is fundamentally reshaping how pet food manufacturers approach product efficacy and quality control. By integrating science-backed gut health additives with automated sampling infrastructure, Hollison enables its clients to achieve superior nutritional standards while simultaneously optimizing production line efficiency. Their unique value proposition lies in the synthesis of biological health benefits and mechanical engineering, ensuring that pet food products maintain high integrity from the manufacturing floor to the consumer bowl.
How much funding has Hollison raised?
Hollison has raised a total of $315K across 2 funding rounds:
Debt
$150K
Debt
$165K
Debt (2020): $150K with participation from PPP
Debt (2021): $165K led by PPP
Key Investors in Hollison
PPP
Public-Private Partnership
What's next for Hollison?
With this late-stage capital, Hollison is positioned to scale its operational footprint and deepen its research and development capabilities. The strategic focus will likely shift toward expanding the adoption of its automated sampling systems, which are essential for manufacturers aiming to meet increasingly stringent regulatory and quality benchmarks. Furthermore, the company is expected to leverage this financial backing to enhance its probiotic supply chain, ensuring that its science-backed solutions remain accessible and cost-effective for large-scale pet food producers. As the industry continues to prioritize pet wellness, Hollison's dual-pronged approach of biological innovation and operational automation provides a clear pathway for sustained growth and market leadership.
See full Hollison company page
